A cancer vaccine breakthrough sent Moderna's stock up more than 176% before a sharp pullback — a reminder of the risks ...

Merck Foundation ( the philanthropic arm of Merck KGaA Germany, together with First Ladies of Africa and Asia and their partners including Ministries of Health, Medical Societies and Academia, is ...

Your resource for the hottest moving stocks and news. We cover all sectors and markets giving everyday investors access to ...

Morningstar raised its 2035 Intismeran sales forecast to $16.8 billion and said the result “bodes well” for studies in larger ...

Moderna and Merck said an experimental cancer vaccine paired with Keytruda helped prevent the recurrence of melanoma in a Phase 3 trial. In 2019, a friend noticed a suspicious mole on Angela Evatt's ...

The biotech giant posted positive trial results of a cancer vaccine, boosting shares at a record-setting pace before ...

In a regulatory filing on August 10, pharmaceutical titan Merck & Company, Inc. (NYSE:MRK) disclosed holding 1,214,126 shares ...

US drugmakers Merck and Moderna said Wednesday a personalised cancer treatment had shown success in reducing the recurrence ...

After demand for its COVID-19 shots plummeted, its new treatment for melanoma has reversed the Mass. company’s fortunes.

After surging an astounding 177% in a single trading session, the market’s bullish momentum behind this biotech asset clearly ...

Shares of company stock (NYSE: MRK) were trading at $151.14 at lunchtime, slightly down from Wednesday's record closing high ...